ANGPT1 and COVID-19: ACE inhibitors may potentially attenuate the COVID-19 associated “cytokine storm” by upregulating ACE2, which converts Ang II to Ang (1–7) and activate MAS receptors producing beneficial vasodilatory and anti-inflammatory effects that were shown to play a potential role regarding post-infection of COVID-19 [35].